Alogliptin Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With Biguanides
NCT01964976 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1096
Last updated 2017-04-13
Summary
To examine the safety and efficacy of long-term combination therapy with alogliptin (Nesina) and biguanides in participants with type 2 diabetes mellitus who responded inadequately to treatment with biguanides in addition to diet therapy and exercise therapy.
Conditions
- Surveillance
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Postmarketing Group Manager · Takeda
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-07-31
- Primary Completion
- 2014-12-31
- Completion
- 2014-12-31
Countries
- Japan
Study Locations
More Related Trials
-
A Study for Post-Marketing Surveillance of Nesina® Tablet Monotherapy or Combination Therapy in Participants With Type 2 Diabetes (T2DM) in South Korea
NCT04980040 ·Status: COMPLETED
-
Long-term Safety Study of Alogliptin Used in Combination With Sulfonylurea or Metformin in Participants With Type 2 Diabetes in Japan
NCT01318135 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of Alogliptin Used Combination With Metformin in Participants With Type 2 Diabetes in Japan
NCT01318109 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Double-Blind Comparison Between Mitiglinide and Nateglinide in Type 2 Diabetic Patients
NCT00461617 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Alogliptin on Glycemic Control in Subjects With Type 2 Diabetes.
NCT00755846 ·Status: COMPLETED ·Phase: PHASE2
-
Non-Interventional Study of the Use of Alogliptin and Alogliptin Fixed-Dose Combinations With Pioglitazone and With Metformin in Standard Clinical Practice
NCT02989649 ·Status: TERMINATED
-
A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes
NCT00839527 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Safety Study of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan
NCT01263509 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of Alogliptin Plus Metformin in Patients With Type 2 Diabetes
NCT01023581 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes in Japan
NCT01263470 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes
NCT01289119 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Determine the Long Term Safety and Efficacy of Albiglutide in Combination With Oral Monotherapy Antihyperglycemic Medications in Japanese Patients With Type 2 Diabetes Mellitus
NCT01777282 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Alogliptin Plus Metformin Compared to Glipizide Plus Metformin in Patients With Type 2 Diabetes Mellitus
NCT00856284 ·Status: COMPLETED ·Phase: PHASE3
-
Alogliptin/Pioglitazone (Liovel) Combination Tablets Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus
NCT01990300 ·Status: COMPLETED
-
Long-term Safety Study of MP-513 as Monotherapy or in Combination With Sulfonylurea in Japanese Type 2 Diabetic Patients
NCT02314637 ·Status: COMPLETED ·Phase: PHASE3
-
A Monotherapy Study to Evaluate the Efficacy and Safety of 2 Dose Levels of Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)
NCT01733758 ·Status: COMPLETED ·Phase: PHASE3
-
A Post-Marketing Surveillance Study on NesinaAct® Tablet Use Among Type 2 Diabetes Mellitus Participants in Korea
NCT04980014 ·Status: COMPLETED
-
Efficacy and Safety of Alogliptin Used in Combination With Sulfonylurea in Participants With Type 2 Diabetes in Japan
NCT01318083 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Nateglinide: a Double Blind Add-on Study With Pioglitazone for Type 2 Diabetic Patients
NCT00189774 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan
NCT01263483 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Long-Term Safety Study of MT-2412 in Japanese Patients With Type 2 Diabetes
NCT02220907 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Alogliptin and Metformin Fixed-Dose Combination in Participants With Type 2 Diabetes
NCT01890122 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Safety Study of MP-513 in Patients With Type 2 Diabetes
NCT01301833 ·Status: COMPLETED ·Phase: PHASE3
-
Voglibose Tablets 0.2 / OD Tablets 0.2 Special Drug Use Surveillance "Long-term Use in Patients With Impaired Glucose Tolerance"
NCT01993927 ·Status: COMPLETED
-
Double-blind Comparative Study of SYR-472
NCT01632007 ·Status: COMPLETED ·Phase: PHASE3